Simplify Logo

Full-Time

Senior Reagents Buyer/Planner

Confirmed live in the last 24 hours

Ultima Genomics

Ultima Genomics

201-500 employees

High-throughput genomic sequencing services

Healthcare
Biotechnology

Compensation Overview

$100k - $120kAnnually

+ Bonus + Equity + Benefits

Senior, Expert

Fremont, CA, USA

Category
Computational Biology
Genomics
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • BS in supply chain management, logistics, business management or related fields
  • 5+ years’ experience in procurement role or related position
  • Excellent organizational, communication and time management skills
  • Proven knowledge of inventory management, project management, should-cost models, and supplier negotiation
  • Working knowledge of data analysis and forecasting tools and ability to develop actionable insights from data
  • Interpersonal skills and ability to build, develop and maintain trusting relationships both internally and externally
  • Strong ability to manage and prioritize multiple projects while maintaining accuracy and meeting deadlines; able to balance short-term, urgent needs with long-term strategic initiatives
Responsibilities
  • Execute material planning and procurement activities
  • Review and analyze forecasts and production plans to create strategic sourcing plans for consumables manufacturing
  • Ensure timely materials availability for production
  • Proactively monitor suppliers’ capacity and material constraints to prevent supply chain disruptions
  • Manage supplier relationships, lead issue resolution related to purchase orders
  • Identify and evaluate supply risks - propose and execute action plans to mitigate the supply risks
  • Assess market conditions, identify industry best practices and emerging trends to identify new cost reduction and value creation opportunities
  • Support data analysis needed for strategic supplier analysis, supplier quality initiatives, and other compliance requirements
  • Lead cross-functional teams to find, assess, and select suppliers that will improve value to the organization and help attain targeted business results
  • Other duties and tasks assigned to support NPI and Supplier Quality

Ultima Genomics improves human health through advanced genomic sequencing technologies, processing large amounts of genetic data to provide insights into biology and diseases. Its unique sequencing architecture allows for extensive data collection, detection of small genetic variations, and routine testing for early disease detection. This capability gives clients, including researchers and healthcare providers, access to high-quality genomic information. The company's goal is to continuously innovate and expand its services to enable significant advancements in understanding and treating diseases.

Company Stage

Seed

Total Funding

$631.8M

Headquarters

Newark, New Jersey

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

0%

2 year growth

-7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Ultima Genomics' partnerships with organizations like Hartwig Medical Foundation and Genome Insight enhance their capabilities in precision oncology and cancer diagnostics.
  • The commercial launch of the UG 100 system positions Ultima Genomics as a leader in the high-throughput genomics market, potentially driving significant revenue growth.
  • Their continuous innovation and advancements in sequencing technology could lead to groundbreaking discoveries and improvements in human health.

What critics are saying

  • The high cost of developing and maintaining advanced sequencing technologies could strain Ultima Genomics' financial resources.
  • The competitive landscape in the genomics industry is intense, with numerous players vying for market share, which could impact Ultima's growth.

What makes Ultima Genomics unique

  • Ultima Genomics' UG 100 system and ppmSeq technology offer significantly lower sequencing costs and ultra-high accuracy, setting them apart from traditional sequencing technologies.
  • Their focus on making whole genome sequencing affordable and accessible for cancer diagnostics is a unique value proposition in the genomics market.
  • The company's innovative sequencing architecture, featuring an open silicon wafer substrate, enables the $100 genome, a groundbreaking achievement in the industry.